Kodiak(KOD) - 2024 Q2 - Quarterly Results

Exhibit 99.1 Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2024 Financial Results Palo Alto, CA — August 14, 2024 – Kodiak Sciences Inc. (Nasdaq: KOD), today reported business highlights and financial results for the quarter ended June 30, 2024. "Our three clinical programs of tarcocimab, KSI-501 and KSI-101 are making strong operational progress," said Victor Perlroth, M.D., Chief Executive Officer of Kodiak Sciences. "The Phase 3 GLOW2 study of tarcocimab in diabetic retinopathy ...